Parkside Financial Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Sell
1,422
-101
-7% -$8.33K 0.01% 640
2025
Q4
$130K Buy
1,523
+59
+4% +$4.84K 0.01% 601
2025
Q3
$114K Buy
1,464
+9
+0.6% +$703 0.01% 620
2025
Q2
$114K Buy
1,455
+130
+10% +$9.7K 0.01% 605
2025
Q1
$96K Buy
1,325
+28
+2% +$2K 0.01% 597
2024
Q4
$96K Buy
1,297
+205
+19% +$14.3K 0.01% 584
2024
Q3
$72.1K Sell
1,092
-109
-9% -$7.92K 0.01% 648
2024
Q2
$111K Buy
1,201
+107
+10% +$9.47K 0.02% 489
2024
Q1
$105K Sell
1,094
-31
-3% -$2.6K 0.02% 513
2023
Q4
$85.8K Buy
1,125
+164
+17% +$11.4K 0.02% 528
2023
Q3
$66.6K Sell
961
-209
-18% -$16.8K 0.02% 532
2023
Q2
$110K Buy
1,170
+27
+2% +$2.35K 0.03% 387
2023
Q1
$94.6K Buy
1,143
+99
+9% +$7.78K 0.03% 407
2022
Q4
$77.9K Buy
1,044
+50
+5% +$3.85K 0.02% 443
2022
Q3
$82K Buy
994
+44
+5% +$4.23K 0.03% 389
2022
Q2
$90K Sell
950
-2
-0.2% -$207 0.03% 369
2022
Q1
$112K Buy
952
+86
+10% +$9.65K 0.03% 337
2021
Q4
$112K Buy
866
+166
+24% +$19.4K 0.03% 342
2021
Q3
$79K Buy
700
+84
+14% +$9.59K 0.02% 372
2021
Q2
$64K Buy
616
+19
+3% +$1.79K 0.02% 438
2021
Q1
$50K Buy
597
+18
+3% +$1.52K 0.02% 484
2020
Q4
$53K Buy
579
+16
+3% +$1.33K 0.02% 447
2020
Q3
$45K Sell
563
-1
-0.2% -$78 0.02% 434
2020
Q2
$39K Buy
564
+39
+7% +$2.77K 0.01% 473
2020
Q1
$33K Sell
525
-198
-27% -$14.3K 0.01% 448
2019
Q4
$56K Sell
723
-27
-4% -$2.11K 0.02% 411
2019
Q3
$55K Hold
750
0.02% 386
2019
Q2
$46K Buy
750
+9
+1% +$544 0.01% 416
2019
Q1
$47K Buy
741
+282
+61% +$16.1K 0.02% 392
2018
Q4
$23K Buy
459
+156
+51% +$7.89K 0.01% 530
2018
Q3
$17K Sell
303
-6
-2% -$293 0.01% 644
2018
Q2
$15K Buy
309
+27
+10% +$1.26K 0.01% 657
2018
Q1
$13K Buy
282
+72
+34% +$3.13K ﹤0.01% 666
2017
Q4
$8K Sell
210
-381
-64% -$14K ﹤0.01% 775
2017
Q3
$22K Sell
591
-90
-13% -$3.43K 0.01% 515
2017
Q2
$27K Buy
681
+243
+55% +$8.87K 0.01% 458
2017
Q1
$14K Sell
438
-600
-58% -$18.8K 0.01% 614
2016
Q4
$32K Sell
1,038
-738
-42% -$23.9K 0.01% 423
2016
Q3
$71K Buy
1,776
+570
+47% +$21.5K 0.03% 298
2016
Q2
$40K Sell
1,206
-87
-7% -$2.98K 0.02% 387
2016
Q1
$38K Sell
1,293
-87
-6% -$2.4K 0.02% 388
2015
Q4
$36K Buy
1,380
+114
+9% +$2.96K 0.02% 392
2015
Q3
$30K Buy
+1,266
New +$30.6K 0.02% 398

Other funds holding EW

Parkside Financial Bank & Trust's EW Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Edwards Lifesciences (EW) stake by 6.6% in Q1 2026, selling an estimated $8.33K and leaving 1,422 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #640.

Parkside Financial Bank & Trust first reported a position in EW in Q3 2015 and has held it in 43 quarters since. The position peaked at $130K in Q4 2025. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,422 shares of Edwards Lifesciences worth $114K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 101 Edwards Lifesciences shares in Q1 2026, an estimated $8.33K.
  • Edwards Lifesciences made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #640 holding.
  • Parkside Financial Bank & Trust first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 43 quarters since.
  • Parkside Financial Bank & Trust's Edwards Lifesciences position peaked at $130K in Q4 2025.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.